Diabetes News

In this video, David Nathan, MD, discusses the effects of COVID-19 on patients with type 2 diabetes.

In this video, David Nathan, MD, discusses the need to bring awareness to the risk factors that lead to the diagnosis of type 2 diabetes.

In this video, David Nathan, MD, discusses the action needed by primary care physicians to help inform and treat patients at risk for type 2 diabetes.

In this video, David Nathan, MD, discusses the side effects of weight loss caused by type 2 diabetes medications and the risks of prescribing these medications to patients without diabetes.

Shortages of tirzepatide, a GIP/GLP-1 dual agonist approved for the treatment of type 2 diabetes and obesity, have been resolved, the FDA announced.

Researchers found that women who slept less than 7 hours per night at 24 to 28 weeks’ gestation were more likely to have a child with neurodevelopmental delays compared with those who slept 7 hours or more per night.

In this video, David Nathan, MD, discusses the various treatment options for patients with diabetes.

One of many challenges parents face when their child is diagnosed with diabetes is how the condition will be managed in school, particularly if the child is using a diabetes device.

Decreases in body weight and HbA1c induced by GLP-1 receptor agonists and other diabetes drugs can reduce the risk for cardiometabolic complications for adults newly diagnosed with type 2 diabetes, researchers reported.

A recently proposed U.S. Senate bill aims to crack down on social media influencers and others online who make misleading comments about pharmaceutical drugs.